Article | September 26, 2022

Digital Medicine Society Accelerates Recruitment and Results With Medrio's eConsent

Source: Medrio
Preparing For eConsent - A Step By Step Guide For Site Personnel

The Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy Medrio’s eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients with atopic dermatitis. The multiphase study is part of an ongoing pre-competitive collaboration with leading pharmaceutical companies, including AbbVie, Janssen, Novartis, Pfizer, and UCB, facilitated by DiMe.

“The aim is to generate reliable scientific evidence that drugmakers, medical device companies, researchers and others can use to develop new digital measurements aiding the research and care for people with eczema,” said DiMe CEO Jennifer Goldsack. “Greater standardization among measures could make it less costly to develop new therapies and get them on the market faster.”

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader